<DOC>
	<DOCNO>NCT02004353</DOCNO>
	<brief_summary>The purpose study collect patient relate benefit data follow treatment permanent hearing loss hearing implant company Cochlear period 2 year post treatment . Assessment benefit base standard questionnaire hear ability quality life general .</brief_summary>
	<brief_title>Observation Benefits Patients Implanted With Hearing Implant Company Cochlear</brief_title>
	<detailed_description>The clinical investigation design prospective repeat measure longitudinal study intra-subject control , use selection subjective evaluation tool assess patient relate benefit hear implant treatment permanent hearing loss . Clinically standard self-assessment scale , threshold measure general hear history profile questionnaires clinician implant recipient make available selection interface central electronic platform . The registry aim collection data patient already make decision together implant centre clinician implant device company Cochlear . Patients approach registry participation follow implant care clinician consecutive voluntary basis condition sign patient inform consent . Monitoring data entry include automated reminder via e-platform inherent audit trail .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Postlingually deafen adult adolescent newly implant AND prior first switchon external device Unilateral , bilateral simultaneous recipient implant device ( ) available market approval company Cochlear® Children 10 year old accordance local regulation product label Mentally capable respond selfadministered assessment scale Willingness participate sign Patient Informed Consent form Individuals exclude participation registry accord national local regulation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Cochlear® Hearing Implants</keyword>
</DOC>